ArticleProceedings of the National Academy of Sciences of the United States of America2020

Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways.

Ioannis K Zervantonakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.